Issues related to the accessibility and affordability of healthcare, surprise medical billing.
2026 · 1st Quarter (Jan 1 - Mar 31)
AMERICA'S HEALTH INSURANCE PLANS
Filed by MEHLMAN CONSULTING, INC..
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 20, 2026
- Income
- $90,000.00
- Expenses
- Not reported
- Registrant
- MEHLMAN CONSULTING, INC.
- Filing UUID
- d7b316d0-5353-4901-8a08-76e9bfc5f5d4
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to Medicare payments and Medicare Advantage Prescription Drug Pricing. Medicaid S.1105 - No UPCODE Act CY 2027 Medicare Advantage Rate Notice.
Literal federal measure citations: S.1105
Enhanced premium tax credits Issues related to HSAs. H.R.247/S.46 - Health Care Affordability Act of 2025
Prescription drug pricing.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.